Estimates of wildlife trade for traditional Asian medicine should include that of the caterpillar fungus Ophiocordyceps sinensis (Nature 480, S101–S103; 2011).
The fungus, used to treat asthma and other diseases, is legally harvested on a huge scale in Tibet and the Himalayas, and is one of the world's most expensive natural medical resources. Some 85–185 tonnes are collected annually by the local population for a global market worth between US$5 billion and $11 billion.
Large increases in the price (up by 900% from 1997 to 2008) and trade of caterpillar fungus have encouraged more intensive harvesting. My informal survey of harvesters in the Himalayas reveals that caterpillar fungus abundance is dwindling: the average harvest per collector dropped by around half between 2006 and 2010. Harvesters are extending their range as a result, risking overexploitation of a pristine landscape and more ecosystem degradation.
Conservation efforts must be initiated to halt the decline of this species, which is causing a loss of biodiversity and threatening local livelihoods.
About this article
Cite this article
Shrestha, U. Asian medicine: A fungus in decline. Nature 482, 35 (2012). https://doi.org/10.1038/482035b
This article is cited by
Harvesters’ perceptions of population status and conservation of Chinese caterpillar fungus in the Dolpa region of Nepal
Regional Environmental Change (2015)
An assessment of Yarsagumba (Ophiocordyceps sinensis) collection in Dhorpatan Hunting Reserve, Nepal
Journal of Mountain Science (2014)